Giant Biogene Holding Co., Ltd.

SEHK:2367 Stock Report

Market Cap: HK$52.4b

Giant Biogene Holding Past Earnings Performance

Past criteria checks 6/6

Giant Biogene Holding has been growing earnings at an average annual rate of 21.1%, while the Personal Products industry saw earnings growing at 1.5% annually. Revenues have been growing at an average rate of 49.4% per year. Giant Biogene Holding's return on equity is 29.5%, and it has net margins of 39.7%.

Key information

21.1%

Earnings growth rate

21.2%

EPS growth rate

Personal Products Industry Growth8.8%
Revenue growth rate49.4%
Return on equity29.5%
Net Margin39.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Giant Biogene Holding Co., Ltd. (HKG:2367) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 20
Giant Biogene Holding Co., Ltd. (HKG:2367) Shares Could Be 50% Below Their Intrinsic Value Estimate

Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Aug 21
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Aug 09
Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Jul 01
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Apr 17
Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Mar 28
Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 27
Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

Dec 24
Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

Revenue & Expenses Breakdown

How Giant Biogene Holding makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SEHK:2367 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,4591,7681,61690
31 Mar 243,9921,6101,43882
31 Dec 233,5241,4521,26075
30 Sep 233,2551,2521,18367
30 Jun 232,9851,0521,10659
31 Mar 232,67587496252
31 Dec 222,36469681844
31 Dec 211,55280941925
31 Dec 201,19082618713
31 Dec 1995755212211

Quality Earnings: 2367 has high quality earnings.

Growing Profit Margin: 2367's current net profit margins (39.7%) are higher than last year (35.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2367's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: 2367's earnings growth over the past year (68.1%) exceeds its 5-year average (21.1% per year).

Earnings vs Industry: 2367 earnings growth over the past year (68.1%) exceeded the Personal Products industry 59.2%.

Return on Equity

High ROE: 2367's Return on Equity (29.5%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 03:55
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Giant Biogene Holding Co., Ltd. is covered by 28 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Junhao FanChina International Capital Corporation Limited
Zhuonan XuChina International Capital Corporation Limited
Joseph WongChina Merchants Securities (HK) Co., Ltd